Foresite Capital Fund II is a Venture Capital Fund in California with $308.54 mm assets under management. It has 140 beneficial owners. Data from SEC filing.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
IRS number
901029166
AUM ?
$308.54 mm
Address
Foresite Capital Fund II
600 MONTGOMERY STREET
SUITE 4500
SAN FRANCISCO
CA 94111
600 MONTGOMERY STREET
SUITE 4500
SAN FRANCISCO
CA 94111
Phone
415-877-4887
Ownership
| Fund structure | AUM | Fund type |
|---|---|---|
| Foresite Capital | $3.91 bn | |
| Foresite Capital Fund I, LP | $128.99 mm | Venture Capital Fund |
| Foresite Capital Fund II, LP | $308.54 mm | Venture Capital Fund |
| Foresite Capital Fund III, LP | $283.12 mm | Venture Capital Fund |
| Foresite Capital Fund IV, LP | $1.60 bn | Venture Capital Fund |
| Foresite Capital Fund V, L.P. | $1.08 bn | Venture Capital Fund |
| Foresite Capital Fund VI LP | Venture Capital Fund | |
| Foresite Capital Fund VI (Feeder), LP | ||
| Foresite Capital Opportunity Fund V, L.P. | $316.10 mm | Venture Capital Fund |
| Foresite Capital Vi-a, LLC | $18.12 mm | Venture Capital Fund |
| Foresite Labs Fund I, L.P. | $167.52 mm | Venture Capital Fund |
Latest filings (excl ownership)
Latest ownership filings
SC 13G/A
AERIE PHARMACEUTICALS INC
12 Jun 20
4
James B. Tananbaum
14 May 20
4
James B. Tananbaum
8 May 20
4
James B. Tananbaum
24 Apr 20
4
James B. Tananbaum
15 Apr 20
4
James B. Tananbaum
26 Mar 20
4
James B. Tananbaum
19 Mar 20
4
James B. Tananbaum
2 Mar 20
SC 13G/A
AERIE PHARMACEUTICALS INC
14 Feb 20
SC 13G/A
Aimmune Therapeutics, Inc.
14 Feb 20